Gen-Probe Incorporated  

(Public, NASDAQ:GPRO)   Watch this stock  
Find more results for genprobe
NASDAQ real-time data - Disclaimer
Currency in
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap 3.79B
P/E 0.00
Div/yield     -
EPS 1.04
Shares 45.39M
Beta     -
Inst. own 80%

Key stats and ratios

Q1 (Mar '12) 2011
Net profit margin 14.64% 8.70%
Operating margin 20.65% 15.06%
EBITD margin - 30.48%
Return on average assets 8.41% 4.53%
Return on average equity 12.44% 6.57%
Employees 1,391 -
CDP Score - -


10210 Genetic Center Drive
United States - Map
+1-858-4108000 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Transcripts - SeekingAlpha


Develops, manufactures and markets medical products based on genetic probe technology. The Company's development programs focus on infectious disease diagnostic products. By identifying the genetic material of a disease-causing microorganism (rather than relying on cultures), the Company's products can provide test results within hours. The Company is also using its technology in the research and development of cancer diagnostic products and therapeutic products.